PBH

NYSE · Pharmaceuticals

Prestige Consumer Healthcare

Mid-Cap Stocks Pharmaceutical Stocks Healthcare Stocks

$61.13

-0.87 (-1.40%)

As of Mar 25, 9:59 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 8 80%

Hold 2 20%

Sell 0 0%

Price Target

Analyst Price Target +27.8% upside

Low Target $50.25

Average Target $78.15

High Target $108.25

Current Price $61.13

Current
$61.13

Target
$78.15

$50.25 $78.15 avg $108.25

Scenario Analysis

Bear Case

$50.25

-17.8%

Low target

Base Case

$78.15

+27.8%

Avg target

Bull Case

$108.25

+77.1%

High target

Risk/Reward

4.3x

Highly favorable

Price in Context

52-Week High

$89.37

-31.6% from high

52-Week Low

$57.25

+6.8% from low

50-Day SMA

$64.04

-4.5% vs SMA

200-Day SMA

$69.15

-11.6% vs SMA

RSI (14)

68.6

Neutral

Target vs 52W High

$78.15

-12.6% vs high

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
LLY Eli Lilly and Co.	Strong Buy	39	77%	$1,330.33	+45.2%
JNJ Johnson & Johnson	Buy	32	59%	$299.55	+24.8%
MRK Merck & Co. Inc.	Buy	36	67%	$159.27	+33.4%
PFE Pfizer Inc.	Hold	35	40%	$33.90	+24.3%
BMY Bristol-Myers Squibb Co	Hold	36	42%	$174.50	+196.1%
ZTS Zoetis Inc	Buy	25	64%	$209.87	+79.8%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	16	88%	$36.26	-22.9%
VTRS Viatris Inc	Buy	18	67%	$122.82	+809.8%